Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings.
about
Parkinson's Disease: The Mitochondria-Iron LinkIllicit stimulant use is associated with abnormal substantia nigra morphology in humansHyperechogenicity of the Substantia Nigra in Parkinson's Disease: Insights from Two Brothers with Markedly Different Disease Durations.Transcranial sonography on Parkinson's disease and essential tremor.Is transcranial sonography useful to distinguish scans without evidence of dopaminergic deficit patients from Parkinson's disease?Specificity and sensitivity of transcranial sonography of the substantia nigra in the diagnosis of Parkinson's disease: prospective cohort study in 196 patients.Specificity of transcranial sonography in parkinson spectrum disorders in comparison to degenerative cognitive syndromesRecent imaging advances in the diagnosis and management of Parkinson's diseaseThe predictive value of transcranial duplex sonography for the clinical diagnosis in undiagnosed parkinsonian syndromes: comparison with SPECT scans.Neuroimaging in Parkinson disease: from research setting to clinical practice.Role of iron in neurodegenerative diseases.Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly.Neuroimaging in pre-motor Parkinson's diseaseHyperechogenicity of the substantia nigra: pitfalls in assessment and specificity for Parkinson's disease.Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.Detection of MPTP-induced substantia nigra hyperechogenicity in Rhesus monkeys by transcranial ultrasoundMilestones in magnetic resonance imaging and transcranial sonography of movement disorders.Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.Iron in neurodegenerative disorders.Premotor Parkinson's disease: concepts and definitionsTranscranial sonography and functional imaging in glucocerebrosidase mutation Parkinson diseaseGenetics of iron regulation and the possible role of iron in Parkinson's disease.Transcranial sonography findings related to depression in parkinsonian disorders: cross-sectional study in 126 patients.Dietary iron intake and risk of Parkinson's disease.The search for biomarkers in Parkinson's disease: a critical review.Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases.Proposed neuroimaging criteria for the diagnosis of multiple system atrophy.Transcranial brain sonography findings in Parkinson's disease: implications for pathogenesis, early diagnosis and therapy.Recognition and management of Parkinson's disease during the premotor (prodromal) phase.Copper and copper proteins in Parkinson's disease.Iron-dependent functions of mitochondria--relation to neurodegeneration.Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: no.Biomarkers for attention-deficit/hyperactivity disorder (ADHD). A consensus report of the WFSBP task force on biological markers and the World Federation of ADHD.Biomarkers of Parkinson's disease: current status and future perspectives.Genetic and constitutional factors are major contributors to substantia nigra hyperechogenicity.Transcranial sonography image characteristics in different Parkinson's disease subtypes.Biomarkers in Prodromal Parkinson Disease: a Qualitative Review.Transcranial sonography of the substantia nigra: digital image analysis.Prodromal non-motor symptoms of Parkinson's disease.Substantia Nigra Hyperechogenicity: Validation of Transcranial Sonography for Parkinson Disease Diagnosis in a Large Estonian Cohort.
P2860
Q26746899-F0318E9F-B7E4-4DC2-B25B-02D0173C236DQ28486143-05994557-55ED-4552-8E72-5D6574722510Q30363964-C864070C-4406-4671-9601-F3F80DBD5086Q30450612-B5F1F5EE-3805-465A-9F36-21F13235720EQ30454441-808E1B7E-88B5-452D-BE71-09F07913C824Q30454798-85BA0215-9569-48D4-984B-480E66ADF109Q30468731-D601ED28-CC69-4E28-BEB7-8EC24699DB8EQ30479129-5F965E60-A1CD-4189-A553-259911C2D204Q30851659-5C855FEC-A0D1-4977-890F-C3EFC5B13DA0Q30868628-6CFC38E4-0AD4-4DCD-985B-06AFD1E15FF1Q31038817-9A00B7B4-AEF1-4DF1-8A36-7845A8A56281Q33632441-7990B1F2-0994-438E-B39B-E7B8DD3E8D39Q33676222-953967A6-6FB8-4363-8903-08809A949637Q33689486-06BBEBE1-CFED-4336-A734-00E7542B9491Q33785923-6C45F11F-89F3-4D41-A149-47979077CCE2Q33821309-FD2BC431-BD28-4387-A33A-90F976B7E8FCQ33917085-65428A43-9D00-4120-B9BF-83C9078EC5F4Q34554452-A53BD87D-36B0-4160-98B0-701B1D010209Q35112542-B34A8D7D-C13B-4660-91D3-3C4DCFC6672CQ35910731-7E0A8391-1700-4F50-8F5B-FDFE01DFE9ACQ36595145-A1822FBF-FBB0-4CE8-860A-6333FD7D9FAAQ36815145-B6CCADC3-361A-4FBA-AD37-7F1FC5A74BDDQ36930590-77DDE108-17CD-4E48-B6F6-BA4359DE01C7Q37305887-673665EA-2344-43DB-9340-D5B9B5C236CDQ37352054-53C6C170-AAF4-4739-ABAE-728940752488Q37358672-2BA05174-519C-4734-AC3E-3B2B55DE00A1Q37420656-E2089C45-EFD4-42A7-A7B3-1CE3D4CF085BQ37507963-0E481EBB-B239-46A4-A341-ADD5DD2CC4C0Q37507968-C87F6176-E099-4FC7-BADB-FF810E9FB3BAQ37616391-4F4DB22F-3C9A-47E1-AE4D-244134F7C4FBQ37821334-AF2B3C08-7609-45F8-8F5A-ED535FE6ED9FQ37824440-B9F8259E-817A-4F14-A35F-881CD178F7DBQ38029716-0EA804AB-E15C-460E-9D0A-FCC8C9409BB9Q38043841-3B53678D-2697-4B5F-91BA-DEE97FD4A1ADQ38645895-A89AFF45-75A5-4FFF-84B1-0E4E0AAC42FFQ38654730-C46A3871-FD2F-42FA-A649-1908226E7E48Q38788917-B597A3DA-B529-4A5A-BC94-02399E77C66DQ40210090-F0DF8E0D-9F77-4756-BE2D-FE9D731B64D8Q40247459-949A117F-1484-4879-A533-1E96FF2E8E0BQ40294867-992A9917-D1DA-4224-A282-E0D4B81C735C
P2860
Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings.
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Echogenicity of the substantia ...... relation to clinical findings.
@ast
Echogenicity of the substantia ...... relation to clinical findings.
@en
type
label
Echogenicity of the substantia ...... relation to clinical findings.
@ast
Echogenicity of the substantia ...... relation to clinical findings.
@en
prefLabel
Echogenicity of the substantia ...... relation to clinical findings.
@ast
Echogenicity of the substantia ...... relation to clinical findings.
@en
P2093
P356
P1433
P1476
Echogenicity of the substantia ...... relation to clinical findings.
@en
P2093
P2888
P304
P356
10.1007/S004150170114
P577
2001-08-01T00:00:00Z
P6179
1052913815